AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Immunis.AI to Present at the BIO CEO & Investor Conference

February 6, 2020 GMT

ROYAL OAK, Mich.--(BUSINESS WIRE)--Feb 6, 2020--

Immunis.AI, a privately held immunogenomics company with a patented liquid biopsy platform, today announced that its President and Chief Executive Officer, Mark McDonough, will present at the BIO CEO & Investor Conference being held in New York City from February 10-11, 2020.

Date: Tuesday, February 11 th

Time: 10:00 AM

Track: Diagnostics

Venue: Ziegfeld Room, New York Marriott Marquis, 1535 Broadway, New York, NY 10036

To schedule a meeting with Mark McDonough during the conference, please contact patrickthompson@ententeinc.com.

About Immunis.AI

Immunis.AI is a privately held immunogenomics company with a patented liquid biopsy platform that offers unique insights into disease biology, for a truly individualized assessment. Our Intelligentia™ platform combines the power of the immune defense system, RNAseq technology and machine learning for the development of proprietary disease-specific algorithms. Our approach compares the differential gene expression patterns from two immune cells, using the patient as the control, normalizing and enhancing the signal of the underlying pathology. Intelligentia™ is a disruptive alternative, leveraging the immune system’s surveillance apparatus to overcome the limitations of cfDNA and CTC’s, enabling us to improve early stage disease detection, at the point of immune-escape, when there is the best opportunity for cure. For more information, please visit: immunis.ai

View source version on businesswire.com:https://www.businesswire.com/news/home/20200206005526/en/

CONTACT: Patrick Thompson for Immunis.AI

Patrickthompson@ENTENTEInc.com

M: +1.920.615.2199

O: +1.312.416.8438

KEYWORD: MICHIGAN UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: MEDICAL DEVICES HEALTH TECHNOLOGY SOFTWARE PHARMACEUTICAL BIOTECHNOLOGY

SOURCE: Immunis.AI

Copyright Business Wire 2020.

PUB: 02/06/2020 09:30 AM/DISC: 02/06/2020 09:30 AM

http://www.businesswire.com/news/home/20200206005526/en